Company
Headquarters: Taipei, Taiwan
TW$525.5 Million
TWD as of Jan. 1, 2024
US$17.1 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Welgene Biotech Co.,Ltd. provides clinical testing services. The company offers research services, including sequencing, microarray, quantitative PCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and clinical application services, such as array-based genomic hybridization and non-invasive prenatal tests. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is headquartered in Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Welgene Biotech Co.,Ltd. has the following listings and related stock indices.
Stock: TWSE: 6661 wb_incandescent